<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">docru</journal-id><journal-title-group><journal-title xml:lang="ru">Доктор.Ру</journal-title><trans-title-group xml:lang="en"><trans-title>Title</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-2378</issn><issn pub-type="epub">2713-2994</issn><publisher><publisher-name>ООО "ГК "РУСМЕДИКАЛ"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31550/1727-2378-2022-21-5-6-12</article-id><article-id custom-type="elpub" pub-id-type="custom">docru-122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКУШЕРСТВО И ПЕРИНАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OBSTETRICS AND PERINATOLOGY</subject></subj-group></article-categories><title-group><article-title>Исследование взаимосвязи состава микровезикул крови беременных с последующими плацента-ассоциированными осложнениями</article-title><trans-title-group xml:lang="en"><trans-title>The Study of the Relationship Between Blood Microvesicle Structure in Pregnant Women with Subsequent Placenta-Associated Complications</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Микаелян</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikayelyan</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Микаелян Асмик Гагиковна — аспирант 2-го акушерского отделения патологии беременности</p><p>117997, г. Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>4 Academician Oparin Str., Moscow, 117997</p></bio><email xlink:type="simple">mikaelyan_asmik@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марей</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Marey</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марей Мария Владимировна — научный сотрудник лаборатории митохондриальной медицины</p><p>117997, г. Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>4 Academician Oparin Str., Moscow, 117997</p></bio><email xlink:type="simple">m_marey@oparina4.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булатова</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulatova</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Булатова Юлия Сергеевна — врач акушер-гинеколог 2-го акушерского отделения патологии беременности</p><p>117997, г. Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>4 Academician Oparin Str., Moscow, 117997</p></bio><email xlink:type="simple">yu.bulatova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9201-2281</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тетруашвили</surname><given-names>Н. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Tetruashvili</surname><given-names>N. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тетруашвили Нана Картлосовна — д. м. н., доцент, заместитель директора Института акушерства по научной работе, заведующая отделом медицины плода и 2-м акушерским отделением патологии беременности</p><p>117997, г. Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>4 Academician Oparin Str., Moscow, 117997</p></bio><email xlink:type="simple">tetrauly@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Высоких</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Vysokikh</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Высоких Михаил Юрьевич — к. б. н., доцент, заведующий лабораторией митохондриальной медицины</p><p>117997, г. Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>4 Academician Oparin Str., Moscow, 117997</p></bio><email xlink:type="simple">mikhail.vyssokikh@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI “National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov” Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>16</day><month>02</month><year>2025</year></pub-date><volume>21</volume><issue>5</issue><issue-title>ГИНЕКОЛОГИЯ</issue-title><fpage>6</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Микаелян А.Г., Марей М.В., Булатова Ю.С., Тетруашвили Н.К., Высоких М.Ю., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Микаелян А.Г., Марей М.В., Булатова Ю.С., Тетруашвили Н.К., Высоких М.Ю.</copyright-holder><copyright-holder xml:lang="en">Mikayelyan A.G., Marey M.V., Bulatova Y.S., Tetruashvili N.K., Vysokikh M.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://docru.elpub.ru/jour/article/view/122">https://docru.elpub.ru/jour/article/view/122</self-uri><abstract><p>Цель исследования: выявить взаимосвязь между содержанием сигнальных белковых последовательностей митохондриального происхождения в микровезикулах крови беременных и последующим развитием синдрома задержки роста плода (СЗРП), маловесного плода, преэклампсии (ПЭ) или нормальными массо-ростовыми показателями плодов и новорожденных.Дизайн: проспективное сравнительное исследование.Материалы и методы. Исследована микровезикулярная фракция плазмы крови женщин с наличием плацента-ассоциированных осложнений в исходе предыдущих беременностей как у группы риска повторного их развития (n = 96). Основная группа была разделена на 4 подгруппы: в подгруппу IА входили 32 пациентки, беременность которых осложнилась СЗРП, подгруппа IБ состояла из 20 пациенток, у которых к манифестации СЗРП присоединилась ПЭ, в подгруппу IВ вошли 24 беременные, у которых родились маловесные к сроку гестации дети, подгруппу IГ составили 20 беременных с плацента-ассоциированными осложнениями в анамнезе и аномальными показателями доплерометрии, масса и рост детей которых после рождения не отличались от нормативных значений. Контрольную группу составили 20 женщин с физиологическим течением беременности. Микровезикулярная фракция периферической крови пациенток получена методом дифференциального ультрацентрифугирования плазмы. Определение содержания белка внешней мембраны митохондрий (VDAC1), активатора транскрипции и репликации митохондриальной ДНК (TFAM), белка слияния внешних мембран митохондрий (MFN2), а также белка TAZ, отвечающего за ремоделирование кардиолипина при его окислительном повреждении, проводилось методом вестерн-блот анализа с помощью панели моноклональных антител.Результаты. В микровезикулах плазмы крови пациенток с последующим развитием плацента-ассоциированных осложнений происходило снижение содержания ряда митохондриальных белков (транспортного мембранного белка VDAC1, митохондриального фактора транскрипции TFAM, белков слияния митохондрий MFN2, OPA1). Уровни этих белков и определяют успешность передачи сигнала в рамках межклеточной коммуникации об адекватной функциональной активности митохондрий, их целостности и нормального биогенеза.Заключение. Полученные результаты позволяют сделать заключение о наличии нарушений митохондриального биогенеза у беременных с формирующимися плацента-ассоциированными осложнениями, что, вероятно, вносит серьезный вклад в их развитие.</p></abstract><trans-abstract xml:lang="en"><p>Study Objective: To find the relationship between the levels of mitochondrial signal protein sequences in blood microvesicles of pregnant women and subsequent development of foetal growth retardation syndrome (FGRS), low birth-weight baby, preeclampsia (PE) or foetuses and newborns with normal weight and height.Study Design: Prospective comparative study.Materials and Methods. The microvesicular blood plasma fraction of women with placenta-associated complications in the outcome of previous pregnancies was studied as a risk group for their recurrence (n = 96). The study group was divided into 4 sub-groups: sub-group IА included 32 patients with pregnancies complicated with FGRS; sub-group IB comprised 20 patients with FGRS and PE; sub-group IC included 24 pregnant women, whose newborns were small for gestation age; sub-group ID was 20 pregnant women with a history of placenta-associated complications and abnormal Doppler velocimetry results, whose postnatal weight and height did not differ from normal values. The control group consisted of 20 women with a physiological course of pregnancy. The microvesicular fraction of the peripheral blood of the patients was obtained by differential plasma ultracentrifugation. Protein of the outer membrane of mitochondria (VDAC1), mitochondrial DNA transcription and replication activator (TFAM), recombinant protein of the outer membrane of mitochondria (MFN2), and TAZ protein encoding cardiolipin modelling in oxidative damage were measured by western blot analysis using a monoclonal antibody panel.Study Results. Plasma microvesicles in patients with subsequent placenta-associated complications demonstrated decreased levels of a number of mitochondrial proteins (VDAC1, TFAM, MFN2, OPA1). Levels of these proteins determine successful intercellular signaling on the adequate functional activity of mitochondria, their integrity and normal biogenesis.Conclusion. The obtained results allow to make a conclusion about a pronounced violation of mitochondrial biogenesis in the body of women with intrauterine growth restriction, which probably makes a serious contribution to the development of pathology and its progression.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром задержки роста плода</kwd><kwd>микровезикулы</kwd><kwd>привычный выкидыш</kwd><kwd>плацентарная недостаточность</kwd><kwd>преэклампсия</kwd><kwd>митохондрии</kwd><kwd>беременность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>foetal growth retardation syndrome</kwd><kwd>microvesicles</kwd><kwd>habitual abortion</kwd><kwd>placental insufficiency</kwd><kwd>preeclampsia</kwd><kwd>mitochondria</kwd><kwd>pregnancy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа поддержана финансированием государственного задания «Разработка системы прогнозирования осложнений и исходов беременностей у женщин с привычным выкидышем» № 16-А21.</funding-statement><funding-statement xml:lang="en">The work was supported by State order “Development of a system for predicting complications and outcomes of pregnancies in women with recurrent pregnancy losses” No. 16-А21.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ажибеков С.А., Путилова Н.В., Третьякова Т.Б., Пестряева Л.А. Роль генетически детерминированных особенностей энергетического обмена в формировании плацентарной недостаточности с исходом в синдром задержки роста плода. Акушерство и гинекология. 2016; 11: 11–15. DOI: 10.18565/aig.2016.11.11-5</mixed-citation><mixed-citation xml:lang="en">Azhibekov S.A., Putilova N.V., Tretyakova T.B., Pestryaeva L.A. Role of the inherited characteristics of energy metabolism in the development of placental insufficiency with an outcome to intrauterine growth restriction. Obstetrics and Gynecology. 2016; 11: 11–15. (in Russian) DOI: 10.18565/aig.2016.11.11-5</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">La Rocca C., Carbone F., Longobardi S., Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol. Lett. 2014; 162(1): 41–8. DOI: 10.1016/J.IMLET.2014.06.013</mixed-citation><mixed-citation xml:lang="en">La Rocca C., Carbone F., Longobardi S., Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol. Lett. 2014; 162(1): 41–8. DOI: 10.1016/J.IMLET.2014.06.013</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Romo A., Carceller R., Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr. Endocrinol. Rev. 2009; 6(suppl.3): S332–6.</mixed-citation><mixed-citation xml:lang="en">Romo A., Carceller R., Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr. Endocrinol. Rev. 2009; 6(suppl.3): S332–6.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Stahl P.D., Raposo G. Exosomes and extracellular vesicles: the path forward. Essays in Biochem. 2018; 62(2): 119–24. DOI: 10.1042/EBC20170088</mixed-citation><mixed-citation xml:lang="en">Stahl P.D., Raposo G. Exosomes and extracellular vesicles: the path forward. Essays in Biochem. 2018; 62(2): 119–24. DOI: 10.1042/EBC20170088</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dimuccio V., Ranghino A., Barbato L. P., Fop F. et al. Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS One. 2014; 9(8): e104490. DOI: 10.1371/journal.pone.0104490</mixed-citation><mixed-citation xml:lang="en">Dimuccio V., Ranghino A., Barbato L. P., Fop F. et al. Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS One. 2014; 9(8): e104490. DOI: 10.1371/journal.pone.0104490</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kornek M., Schuppan D. Microparticles: modulators and biomarkers of liver disease. J. Hepatol. 2012; 57(5): 1144–6. DOI: 10.1016/j.jhep.2012.07.029</mixed-citation><mixed-citation xml:lang="en">Kornek M., Schuppan D. Microparticles: modulators and biomarkers of liver disease. J. Hepatol. 2012; 57(5): 1144–6. DOI: 10.1016/j.jhep.2012.07.029</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rackov G., Garcia-Romero N., Esteban-Rubio S., Carrión-Navarro J. et al. Vesicle-mediated control of cell function: the role of extracellular matrix and microenvironment. Front. Physiol. 2018; 9: 651. DOI: 10.3389/fphys.2018.00651</mixed-citation><mixed-citation xml:lang="en">Rackov G., Garcia-Romero N., Esteban-Rubio S., Carrión-Navarro J. et al. Vesicle-mediated control of cell function: the role of extracellular matrix and microenvironment. Front. Physiol. 2018; 9: 651. DOI: 10.3389/fphys.2018.00651</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Valadi H., Ekström K., Bossios A., Sjöstrand M. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol. 2007; 9(6): 654–9. DOI: 10.1038/ncb1596</mixed-citation><mixed-citation xml:lang="en">Valadi H., Ekström K., Bossios A., Sjöstrand M. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol. 2007; 9(6): 654–9. DOI: 10.1038/ncb1596</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Romero N., Esteban-Rubio S., Rackov G., Carrión-Navarro J. et al. Extracellular vesicles compartment in liquid biopsies: clinical application. Mol. Aspects Med. 2018; 60: 27–37. DOI: 10.1016/j.mam.2017.11.009</mixed-citation><mixed-citation xml:lang="en">Garcia-Romero N., Esteban-Rubio S., Rackov G., Carrión-Navarro J. et al. Extracellular vesicles compartment in liquid biopsies: clinical application. Mol. Aspects Med. 2018; 60: 27–37. DOI: 10.1016/j.mam.2017.11.009</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 2011; 3: 15. DOI: 10.3410/b3-15</mixed-citation><mixed-citation xml:lang="en">Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 2011; 3: 15. DOI: 10.3410/b3-15</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chiarello D.I., Abad C., Rojas D., Toledo F. et al. Oxidative stress: normal pregnancy versus preeclampsia. Biochim. Biophys. Acta Mol. Basis Dis. 2020; 1866(2): 165354. DOI: 10.1016/j.bbadis.2018.12.005</mixed-citation><mixed-citation xml:lang="en">Chiarello D.I., Abad C., Rojas D., Toledo F. et al. Oxidative stress: normal pregnancy versus preeclampsia. Biochim. Biophys. Acta Mol. Basis Dis. 2020; 1866(2): 165354. DOI: 10.1016/j.bbadis.2018.12.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma D., Shastri S., Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin. Med. Insights Pediatr. 2016; 10: 67–83. DOI: 10.4137/CMPed.S40070</mixed-citation><mixed-citation xml:lang="en">Sharma D., Shastri S., Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin. Med. Insights Pediatr. 2016; 10: 67–83. DOI: 10.4137/CMPed.S40070</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell M.D., Peiris H.N., Kobayashi M., Koh Y.Q. et al. Placental exosomes in normal and complicated pregnancy. Am. J. Obstet. Gynecol. 2015; 213(4): S173–81. DOI: 10.1016/j.ajog.2015.07.001</mixed-citation><mixed-citation xml:lang="en">Mitchell M.D., Peiris H.N., Kobayashi M., Koh Y.Q. et al. Placental exosomes in normal and complicated pregnancy. Am. J. Obstet. Gynecol. 2015; 213(4): S173–81. DOI: 10.1016/j.ajog.2015.07.001</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vishnyakova P.A., Volodina M.A., Tarasova N.V., Marey M.V. et al. Mitochondrial role in adaptive response to stress conditions in preeclampsia. Sci Rep. 2016; 6: 32410. DOI: 10.1038/srep32410</mixed-citation><mixed-citation xml:lang="en">Vishnyakova P.A., Volodina M.A., Tarasova N.V., Marey M.V. et al. Mitochondrial role in adaptive response to stress conditions in preeclampsia. Sci Rep. 2016; 6: 32410. DOI: 10.1038/srep32410</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vishnyakova P.A., Tarasova N.V., Volodina M.A., Tsvirkun D.V. et al. Gestation age-associated dynamics of mitochondrial calcium uniporter subunits expression in feto-maternal complex at term and preterm delivery. Sci Rep. 2019; 9: 5501. DOI: 10.1038/s41598-019-41996-3</mixed-citation><mixed-citation xml:lang="en">Vishnyakova P.A., Tarasova N.V., Volodina M.A., Tsvirkun D.V. et al. Gestation age-associated dynamics of mitochondrial calcium uniporter subunits expression in feto-maternal complex at term and preterm delivery. Sci Rep. 2019; 9: 5501. DOI: 10.1038/s41598-019-41996-3</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Вишнякова П.А., Суханова Ю.А., Микаелян А.Г., Булатова Ю.С. и др. Синдром задержки роста плода и маркеры митохондриальной дисфункции. Акушерство и гинекология. 2018; 6: 31–6. DOI: 10.18565/aig.2018.6.31-36</mixed-citation><mixed-citation xml:lang="en">Vishnyakova P.A., Sukhanova Yu.A., Mikaelyan A.G., Bulatova Yu.S. et al. Fetal growth restriction and markers for mitochondrial dysfunction. Obstetrics and Gynecology. 2018; 6: 31–6. (in Russian) DOI: 10.18565/aig.2018.6.31-36</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Скрипниченко Ю.П., Баранов И.И., Высоких М.Ю. Определение уровня митохондриальной ДНК в крови для прогнозирования осложнений беременности. Акушерство и гинекология. 2018; 2: 44–9. DOI: 10.18565/aig.2018.2.44-49</mixed-citation><mixed-citation xml:lang="en">Skripnichenko Yu.P., Baranov I.I., Vysokikh M.Yu. Determination of the blood level of mitochondrial DNA for the prediction of pregnancy complication. Obstetrics and Gynecology. 2018; 2: 44–9. (in Russian) DOI: 10.18565/aig.2018.2.44-49</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Desrochers L.M., Bordeleau F., Reinhart-King C.A., Cerione R.A. et al. Microvesicles provide a mechanism for intercellular communication by embryonic stem cells during embryo implantation. Nat. Commun. 2016; 7: 11958. DOI: 10.1038/ncomms11958</mixed-citation><mixed-citation xml:lang="en">Desrochers L.M., Bordeleau F., Reinhart-King C.A., Cerione R.A. et al. Microvesicles provide a mechanism for intercellular communication by embryonic stem cells during embryo implantation. Nat. Commun. 2016; 7: 11958. DOI: 10.1038/ncomms11958</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mincheva-Nilsson L., Baranov V. Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. Am. J. Reprod. Immunol. 2014; 72(5): 440–57. DOI: 10.1111/aji.12311</mixed-citation><mixed-citation xml:lang="en">Mincheva-Nilsson L., Baranov V. Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. Am. J. Reprod. Immunol. 2014; 72(5): 440–57. DOI: 10.1111/aji.12311</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Goswamia D., Tannetta D.S., Magee L.A., Fuchisawa A. et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006; 27(1): 56–61. DOI: 10.1016/j.placenta.2004.11.007</mixed-citation><mixed-citation xml:lang="en">Goswamia D., Tannetta D.S., Magee L.A., Fuchisawa A. et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006; 27(1): 56–61. DOI: 10.1016/j.placenta.2004.11.007</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
